Co-administration of silymarin and deferoxamine against kidney, liver and heart iron deposition in male iron overload rat model

Autor: Navidi-Shishaone, M., Mohhebi, S., Nematbakhsh, M., Roozbehani, S., Ardeshir Talebi, Pezeshki, Z., Eshraghi-Jazi, F., Mazaheri, S., Shirdavani, S., Gharagozloo, M., Moaeidi, B. A.

Publikováno v: Scopus-Elsevier
International Journal of Preventive Medicine, Vol 5, Iss 1, Pp 110-116 (2014)
International Journal of Preventive Medicine

Background: Tissue iron deposition may disturb functions of the organs. In many diseases like thalassemia, the patients suffer from iron deposition in kidney and heart tissues. Deferoxamine (DF) is a synthetic iron chelator and silymarin (SM) is an a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6edca10fbc8e9bfcba1301db56f4b4d7
http://www.scopus.com/inward/record.url?eid=2-s2.0-84893154474&partnerID=MN8TOARS